PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis

Colorectal cancer (CRC) is one of the most common cancers of the digestive tract, and patients with advanced-stage cancer have poor survival despite the use of multidrug conventional chemotherapy regimens. Intra-tumor heterogeneity of cancerous cells is the main obstacle in the way to effective canc...

Full description

Bibliographic Details
Main Authors: Zhilong Yu, Shanshi Tong, Chenyi Wang, Zizhen Wu, Yingjiang Ye, Shan Wang, Kewei Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.1001994/full
_version_ 1797671679420268544
author Zhilong Yu
Shanshi Tong
Chenyi Wang
Zizhen Wu
Yingjiang Ye
Shan Wang
Kewei Jiang
author_facet Zhilong Yu
Shanshi Tong
Chenyi Wang
Zizhen Wu
Yingjiang Ye
Shan Wang
Kewei Jiang
author_sort Zhilong Yu
collection DOAJ
description Colorectal cancer (CRC) is one of the most common cancers of the digestive tract, and patients with advanced-stage cancer have poor survival despite the use of multidrug conventional chemotherapy regimens. Intra-tumor heterogeneity of cancerous cells is the main obstacle in the way to effective cancer treatments. Therefore, we are looking for novel approaches to eliminate just cancer cells including nanoparticles (NPs). PPy@Fe3O4 NPs were successfully synthesized through a portable method. The characterization of transmission electron microscopy (TEM), Fourier-Transformed infrared spectrometer, and X-ray powder diffraction have further proved successful preparation of PPy@Fe3O4 NPs. NIR irradiation was used to test the photothermal properties of NPs and an infrared camera was used to record their temperature. The direct effects of PPy@Fe3O4 NPs on colorectal cancer cell DLD1 were assessed using CCK8, plate clone, transwell, flow cytometry, and western blotting in CRC cell. The effect of PPy@Fe3O4 NPs on neoplasm growth in nude mice was evaluated in vivo. This study demonstrated that PPy@ Fe3O4 NPs significantly inhibit the growth, migration, and invasion and promote ferroptosis to the untreated controls in colorectal cancer cells. Mechanical exploration revealed that PPy@Fe3O4 NPs inhibit the multiplication, migration, and invasion of CRC cells in vitro by modulating the NF-κB signaling pathway. Importantly, Ferroptosis inhibitors Fer-1 can reverse the changes in metastasis-associated proteins caused by NPs treatment. Collectively, our observations revealed that PPy@Fe3O4 NPs were blockers of tumor progression and metastasis in CRC. This study brought new insights into bioactive NPs, with application potential in curing CRC or other human disorders.
first_indexed 2024-03-11T21:19:03Z
format Article
id doaj.art-9ffffe0d3015475fa30e9822424c06b2
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-03-11T21:19:03Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-9ffffe0d3015475fa30e9822424c06b22023-09-28T11:00:02ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-09-011010.3389/fbioe.2022.10019941001994PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosisZhilong Yu0Shanshi Tong1Chenyi Wang2Zizhen Wu3Yingjiang Ye4Shan Wang5Kewei Jiang6Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing, ChinaState Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing, ChinaDepartment of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing, ChinaDepartment of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing, ChinaDepartment of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing, ChinaDepartment of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital, Beijing, ChinaColorectal cancer (CRC) is one of the most common cancers of the digestive tract, and patients with advanced-stage cancer have poor survival despite the use of multidrug conventional chemotherapy regimens. Intra-tumor heterogeneity of cancerous cells is the main obstacle in the way to effective cancer treatments. Therefore, we are looking for novel approaches to eliminate just cancer cells including nanoparticles (NPs). PPy@Fe3O4 NPs were successfully synthesized through a portable method. The characterization of transmission electron microscopy (TEM), Fourier-Transformed infrared spectrometer, and X-ray powder diffraction have further proved successful preparation of PPy@Fe3O4 NPs. NIR irradiation was used to test the photothermal properties of NPs and an infrared camera was used to record their temperature. The direct effects of PPy@Fe3O4 NPs on colorectal cancer cell DLD1 were assessed using CCK8, plate clone, transwell, flow cytometry, and western blotting in CRC cell. The effect of PPy@Fe3O4 NPs on neoplasm growth in nude mice was evaluated in vivo. This study demonstrated that PPy@ Fe3O4 NPs significantly inhibit the growth, migration, and invasion and promote ferroptosis to the untreated controls in colorectal cancer cells. Mechanical exploration revealed that PPy@Fe3O4 NPs inhibit the multiplication, migration, and invasion of CRC cells in vitro by modulating the NF-κB signaling pathway. Importantly, Ferroptosis inhibitors Fer-1 can reverse the changes in metastasis-associated proteins caused by NPs treatment. Collectively, our observations revealed that PPy@Fe3O4 NPs were blockers of tumor progression and metastasis in CRC. This study brought new insights into bioactive NPs, with application potential in curing CRC or other human disorders.https://www.frontiersin.org/articles/10.3389/fbioe.2022.1001994/fullcolorectal cancernanoparticlesmetastasisNF-κBferroptosis
spellingShingle Zhilong Yu
Shanshi Tong
Chenyi Wang
Zizhen Wu
Yingjiang Ye
Shan Wang
Kewei Jiang
PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis
Frontiers in Bioengineering and Biotechnology
colorectal cancer
nanoparticles
metastasis
NF-κB
ferroptosis
title PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis
title_full PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis
title_fullStr PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis
title_full_unstemmed PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis
title_short PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis
title_sort ppy fe3o4 nanoparticles inhibit the proliferation and metastasis of crc via suppressing the nf κb signaling pathway and promoting ferroptosis
topic colorectal cancer
nanoparticles
metastasis
NF-κB
ferroptosis
url https://www.frontiersin.org/articles/10.3389/fbioe.2022.1001994/full
work_keys_str_mv AT zhilongyu ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis
AT shanshitong ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis
AT chenyiwang ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis
AT zizhenwu ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis
AT yingjiangye ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis
AT shanwang ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis
AT keweijiang ppyfe3o4nanoparticlesinhibittheproliferationandmetastasisofcrcviasuppressingthenfkbsignalingpathwayandpromotingferroptosis